April 19, 2016 — Researchers have confirmed that certain heart rhythm medications, when given by paramedics to patients ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
April 19, 2016
April 8, 2016 — New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban) was ...
April 08, 2016
April 1, 2016 — AstraZeneca confirmed that the American College of Cardiology (ACC) and American Heart Association (AHA) ...
April 01, 2016
March 21, 2016 — The use of novel oral anticoagulants (NOACs) will see a substantial rise after an initially sluggish ...
March 21, 2016
March 17, 2016 — Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being ...
March 17, 2016
February 22, 2016 — A new study conducted at Columbia University Medical Center (CUMC) has revealed some of the ...
February 22, 2016February 9, 2016 — Cigna has entered into an outcomes-based contract with the pharmaceutical company Novartis for the ...
February 09, 2016
The following are the late-breaking clinical trial presentations presented at the 2016 American College of Cardiology ...
February 09, 2016
February 9, 2016 — Boston Scientific Corp. announced the Centers for Medicare and Medicaid Services (CMS) will cover ...
February 09, 2016
Feature | Pharmaceuticals | Rosanne M. Crooke, Ph.D.
Familial chylomicronemia syndrome (FCS) is a rare, genetic disease characterized by mutations in genes affecting the ...
January 22, 2016January 4, 2016 — Living with pulmonary arterial hypertension (PH) is challenging, but the chore of treating the rare ...
January 04, 2016
Feature | Genetic Testing | Kevin P. Greene, M.D.
Statins are lifesaving medications — they have been shown to greatly reduce heart attack and other related events by ...
December 22, 2015
December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle factors ...
December 22, 2015
December 17, 2015 — The ROCKET AF Clinical Trial Executive Committee announced its secondary analysis of the phase III ...
December 17, 2015November 24, 2015 —The U.S. Court of Appeals has overturned a federal circuit court’s decision in The Medicines Company ...
November 24, 2015